Yesterday researchers from the Centers for Disease Control and Prevention (CDC) published encouraging findings that showed the antiviral remdesivir and antibodies in the ZMapp treatment regimen were effective in fighting the current strain of Ebola. The findings were published in The Lancet Infectious Diseases.
The study also demonstrated that a reverse-engineered virus that CDC scientists developed served as an admirable substitute for virus circulating in the Democratic Republic of the Congo (DRC), given that they did not have access to the real thing.
Test of 2 field treatments
Credit: CDC Cynthia Goldsmith
See also:
Jul 9 Lancet Infect Dis study
Jul 9 CDC press release
Jul 9 Stat article
Jul 9 Nature editorial
Jul 10 WHO situational report
WHO Ebola dashboard
Jul 9 DRC report
Photo credit: U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
Leave A Comment